BlackRock’s Outlook Therapeutics OTLK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $544K | Sell |
339,896
-902,476
| -73% | -$1.44M | ﹤0.01% | 4349 |
|
|
2025
Q1 | $1.52M | Buy |
1,242,372
+148,850
| +14% | +$182K | ﹤0.01% | 4030 |
|
|
2024
Q4 | $2.07M | Buy |
1,093,522
+48,534
| +5% | +$91.7K | ﹤0.01% | 3974 |
|
|
2024
Q3 | $5.58M | Buy |
1,044,988
+381,492
| +57% | +$2.04M | ﹤0.01% | 3604 |
|
|
2024
Q2 | $4.9M | Buy |
663,496
+159,508
| +32% | +$1.18M | ﹤0.01% | 3648 |
|
|
2024
Q1 | $6.02M | Sell |
503,988
-14,326
| -3% | -$171K | ﹤0.01% | 3547 |
|
|
2023
Q4 | $4.08M | Buy |
518,314
+48,643
| +10% | +$383K | ﹤0.01% | 3693 |
|
|
2023
Q3 | $2.08M | Buy |
469,671
+8,881
| +2% | +$39.3K | ﹤0.01% | 3918 |
|
|
2023
Q2 | $16M | Buy |
460,790
+57,419
| +14% | +$2M | ﹤0.01% | 3106 |
|
|
2023
Q1 | $8.79M | Buy |
403,371
+51,071
| +14% | +$1.11M | ﹤0.01% | 3305 |
|
|
2022
Q4 | $7.61M | Buy |
352,300
+9,475
| +3% | +$205K | ﹤0.01% | 3456 |
|
|
2022
Q3 | $8.36M | Sell |
342,825
-4,955
| -1% | -$121K | ﹤0.01% | 3455 |
|
|
2022
Q2 | $7.09M | Buy |
347,780
+13,774
| +4% | +$281K | ﹤0.01% | 3590 |
|
|
2022
Q1 | $11.9M | Buy |
334,006
+38,068
| +13% | +$1.36M | ﹤0.01% | 3404 |
|
|
2021
Q4 | $8.05M | Buy |
295,938
+4,007
| +1% | +$109K | ﹤0.01% | 3725 |
|
|
2021
Q3 | $12.7M | Buy |
291,931
+4,234
| +1% | +$184K | ﹤0.01% | 3518 |
|
|
2021
Q2 | $14.3M | Buy |
287,697
+200,570
| +230% | +$9.99M | ﹤0.01% | 3434 |
|
|
2021
Q1 | $3.92M | Buy |
+87,127
| New | +$3.92M | ﹤0.01% | 3984 |
|
|
2018
Q2 | – | Sell |
-194
| Closed | -$27K | – | 4994 |
|
|
2018
Q1 | $27K | Sell |
194
-5
| -3% | -$696 | ﹤0.01% | 4477 |
|
|
2017
Q4 | $41K | Buy |
199
+8
| +4% | +$1.65K | ﹤0.01% | 4407 |
|
|
2017
Q3 | $41K | Sell |
191
-11
| -5% | -$2.36K | ﹤0.01% | 4440 |
|
|
2017
Q2 | $32K | Buy |
+202
| New | +$32K | ﹤0.01% | 4516 |
|